Breaking News Bar

Business News and Information

With $334M in cash, Aerie preps to break even

With $334 million in cash, equivalents and investments as of March 31 and its first drug launched, Durham’s Aerie Pharmaceuticals is prepped to break even.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear